Topical surfactant therapy for recurrent herpes simplex infection.
D004338:Drug Combinations / Q000627:therapeutic use; D005500:Follow-Up Studies; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012008:Recurrence; D013501:Surface-Active Agents / Q000627:therapeutic use*
D004338:Drug Combinations; D013501:Surface-Active Agents; C048416:intervir-A; D011092:Polyethylene Glycols